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Abstract: Serum albumin has been identified as an endogenous protein that is integral to early
bone regeneration. We hypothesized that albumin addition to allografts may result in better bone
remodeling than what can be achieved with anorganic xenografts. Sinus elevations were performed
at 32 sites of 18 patients with the lateral window technique. Sites either received filling with an
anorganic bovine bone mineral (ABBM, BioOss, Geistlich, CH) or albumin impregnated allograft
(BoneAlbumin, OrthoSera, AT). After 6-months patients received dental implants and 16 bone core
biopsy samples were obtained from the ABBM filled, and 16 from the BoneAlbumin augmented sites.
The biopsies were examined by histomorphometry and µCT. Percentage of the residual graft in the
BoneAlbumin group was 0–12.7%, median 5.4% vs. ABBM 6.3–35.9%, median 16.9%, p < 0.05. Results
of the µCT analysis showed that the microarchitecture of the augmented bone in the BoneAlbumin
group resembles that of the native maxilla in morphometric parameters Trabecular Pattern Factor
and Connectivity. Our data show that while ABBM successfully integrates into the newly formed
bone tissue as persisting particles, BoneAlbumin is underway towards complete remodeling with
new bone closely resembling that of the intact maxilla.
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1. Introduction
Development of the alveolar ridge is dependent on tooth eruption and loss of teeth results in its
subsequent resorption. The alveolar process is a tooth dependent structure of the jaws [1–4]. During
the first year after tooth removal, there is a 25% decrease in the volume of the ridge, and its width
reduces by 40–60% in the first three years [5,6]. Maxillary sinus pneumatization is characterized
by the maxillary sinus extension into the adjacent bone structure. Alveolar pneumatization has
been reported in at least 50% of the population [7,8]. Sinus pneumatization and alveolar atrophy
frequently cause insufficient bone volume for dental implant placement in the edentulous posterior
maxilla. Maxillary sinus floor augmentation with the lateral window technique is a safe and predictable
surgical intervention to restore the bone volume of the maxillary premolar and molar area [9]. However,
potential complications may include perforation of sinus membrane and bleeding of the alveolar-antral
vascular bundle. Preoperative analysis of high-resolution, three-dimension imaging can be considered
a method of choice to investigate anatomical variations that may cause complications. New surgical
techniques have been reported to prevent intraoperative bleeding during sinus augmentation [10–12].
There are reports of successful application of several bone graft materials in sinus augmentation
i.e., autologous bone, mineralized freeze-dried bone allograft, demineralized freeze-dried bone allograft,
autogenous tooth bone graft material, β-tricalcium phosphate, nanocrystalline hydroxyapatite, bioactive
glass, biphasic ceramic bone substitute, anorganic bovine bone mineral (ABBM), and other xenografts
of bovine and porcine origin [1,13–26]. Autogenous bone grafts are considered the gold standard due
to their osteogenic capacity, however, donor site morbidity and limited availability are disadvantages
of their use. It has been reported that patients have significantly more pain and discomfort in the
postoperative period when autografts are harvested, therefore, one would rather use an exogenous
material in case adequate bone formation can be achieved with it [27].
Allografts overcome the need for a donor region and the limits of harvestable quantity. However,
processing of the allograft not only eliminates the host’s immunogenic activity but also the viable
osteogenic cells and osteoinductive factors [19,22,28]. One such native bone protein that is integral
to regeneration is albumin, which is highly water soluble and washed away during the preservation
process. Several studies showed that albumin induces mesenchymal stem cell growth on the surface
of freeze-dried bone allograft and albumin impregnation of the bone allograft results in better
bone formation even in challenging applications [29–36]. These preclinical and orthopedic studies
have shown the biological advantages of BoneAlbumin, raising the possibility that it may also
be advantageous in sinus floor augmentation. However, the alveolar ridge of the maxilla poses
anatomical challenges to bone grafting and it is not apparently evident if the advantages offered by
albumin-impregnation, such as stem cell mobilization and faster remodeling are indeed useful in this
location. For example, the maxilla has a fast bone turnover and very high vascularization which may
result in accelerated resorption of the graft material before adequate now bone is formed. Further
complicating this site is the high anatomical variation of the sinus cavity septa and arteries that require
careful preoperative planning [10–12].
The aim of this prospective randomized study is to evaluate the remodeling capacity of albumin
impregnated freeze-dried bone allograft in sinus floor augmentation by histolomorphometry and µCT
analysis and to compare it to anorganic bovine xenograft material.
2. Materials and Methods
Patients who were periodontally healthy, more than 18 years of age, and needed implant-supported
fixed restoration in the maxillary premolar and molar region were included in this study. The exclusion
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criteria were as follows: history of uncontrolled systemic diseases known to alter bone metabolism
(osteoporosis, diabetes mellitus) or contraindicate oral surgical treatment (tumors and inflammations
affecting the maxillary sinuses and the alveolar ridges), patients who were taking or had taken
medications known to modify bone metabolism (bisphosphonates, corticosteroids) or had been
subjected to irradiation of the maxillofacial region, unwillingness to return for follow-up examinations,
smoking, or being pregnant at the time of inclusion. The procedures included in the study were
thoroughly explained to the patients, and they signed informed consent forms. The study was approved
by the Regional and Institutional Committee of Science and Research Ethics (52158-2/2015/EKU
[0425/15]) and The Office of the Chief Medical Officer of The National Public Health and Medical Officer
Service (IF-14561-10/2015). The study was conducted in accordance with the Helsinki declaration.
Preoperative planning was performed with the help of cone beam computed tomography (cbCT)
and septal sinuses and arterial variations were taken in to consideration when selecting the sites for
inclusion in the study [10–12]. Patients performed oral rinse with 0.2% chlorhexidine solution for
1 min before surgery. Under local anesthesia a full thickness flap was raised from a midcrestal incision
along with two relieving incisions. Lateral window osteotomies were carried out with diamond burs.
The Schneiderian membrane was carefully elevated. Bone graft material (2–3 cm3) was packed in the
defect with light force. Patients were randomly assigned to 2 groups based on the type of bone filler:
albumin impregnated allograft (BoneAlbumin, OrthoSera GmbH, Krems an der Donau, Austria) or
anorganic bovine bone mineral (ABBM), (Bio-Oss Geistlich Wolhusen, Switzerland). A porcine collagen
membrane (Bio Gide, Geistlich GmbH, Wolhusen, Switzerland) was placed over the lateral window and
fixed by titanium pins (Titan Pin Set, Ustomed Instruments Ulrich Storz GmbH & Co. KG, Tuttlingen,
Germany). The buccal flap was mobilized to allow tension-free primary closure. The margins were
stabilized with single interrupted sutures. Antibiotics (1 g amoxicillin-clavulanate twice a day for
5 days, or in case of side effects or known allergy to penicillin, 300 mg clindamycin 4 times a day
for 4 days), anti-inflammatory drugs (50 mg diclofenac 3 times a day for 3 days), and chlorhexidine
mouthwash (twice a day for 21 days from the first day after surgery) were prescribed. Sutures were
removed after 10 days. During the healing period, patients either received temporary prostheses that
were in no contact with the surgical area or did not wear them at all. After 6-month healing period,
clinical examination and a cbCT was performed followed by surgical re-entry procedure under local
anesthesia. A bone core biopsy was taken with a trephine with an external diameter of 3.5 mm and an
internal diameter of 2.5 mm (330 205 486 001 025 Hager & Meisinger GmbH, Neuss, Germany) and
implants of at least 4.0 mm of diameter were placed into the grafted alveolus nonsubmerged. The bone
core biopsy samples were removed, pushed out from the trephine, and placed in sample holders filled
with 4% formaldehyde solution in 0.1 M phosphate buffer saline (PBS), pH 7.3, stored at 4 ◦C. Final
prosthetic restorations were cemented after 3 months.
Altogether 32 biopsy samples were taken in 18 patients (BoneAlbumin group: 16 implants placed
in 12 sinus lifts in 9 patients (3 male), age 54.7 ± 6.5 years, ABBM group: 16 implants placed in 11 sinus
lifts in 9 patients (2 male), age 51.1± 15.8 years). Figure 1 presents pre- and postoperative cbCT images
of the augmented sinuses.
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Figure 1. Presents pre- and postoperative cone beam computed tomography (cbCT) images of the
augmented sinuses in both study groups. (A) preoperative and (B) postoperative images of one of
the patients of the BoneAlbumin group, (C) preoperative and (D) postoperative images of one of the
patients in the ABBM group. On each image the coronal view is presented on the upper left, the sagittal
view is presented on the upper right and the axial view is presented on the lower left window.
Bone core biopsy material was fixed in 10% buffered formaldehyde solution. Following decalcination
and dehydration, the biopsy material was embedded in paraffin and 20 µm sections were prepared.
The sections were stained with routine haematoxylin-eosin stain. Sections were evaluated under a light
microscope in magnification 40×–400×.
Histomorphometric measurements were completed on sections with Panoramic Viewer 1.15
(3DHISTECH Ltd., Budapest, Hungary) using a combinatio of Adobe PhotoShop (Adobe Syst m Inc.,
San Jose, CA, USA) and ImageJ, the public dom in NIH Image p ogram (US National Institutes of
Health’ http://rsb.info.nih.gov/nih-image/) at 150× magnification. Two slides of the augmented
areas in each bone core biopsy sample were evaluated to record area percentage of newly formed
bone, residual particles of the bone graft material, and the bone marrow space according to published
protocols [37,38]. Histomorphometric data consisted of the area percentage of newly formed bone,
residual particles of the graft material and bone marrow were identified in each section by an
investigator blinded to the treatment group.
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The bone core biopsy samples were scanned using a microcomputed tomography (µCT) scanner
(Skyscan 1172 X-ray microtomograph, Bruker µCT, Kontich, Belgium). Bone core biopsy samples were
scanned in a 4% buffered formaldehyde solution. Scanning was carried out at a resolution of 5.9 µm
(70 kV, 124 µA). A 0.5 mm aluminium filter was used to reduce image noise. Average scan duration
was 25 min. After the acquisition, raw images were reconstructed by using NRecon software (v.1.7.1.6.,
Bruker µCT, Kontich, Belgium). Ring artefact correction was 10, and the beam hardening correction
was 61%. The morphometric variables relevant to our study calculated by CTAn software (v.1.17.7.2,
Bruker µCT, Kontich, Belgium) and their definitions are listed in Table 1 [39,40]. On the reconstructed
images of each sample the demarcation plane of the host and the augmented area was identified and
the complete available tissue (maxilla or augmented bone, respectively) were selected as regions of
interest (ROIs) for quantitative analysis. Since the length of the biopsy depended on the thickness of
the ridge and the graft/host ratio was variable among the patients the volumes of the selected ROIs
were not uniform throughout the study. Therefore, we opted for measuring the complete available
sample and analyze the data using volume-independent metrics.
Table 1. The morphometric variables relevant to our study calculated by the CTAn software (according
to Bouxsein, M.L., et al. (2010), Gunderson, H.J.G., et al. (1993) and the manual Bruker MicroCT
Morphometric parameters measured by CT-analyzer software 1.15.4.0 by Bruker microCT).
Abbreviation Variable Description Standard Unit
BV/TV Bone volume fraction Relative volume of calcified tissue in the selectedvolume of interest (VOI). %
Tb.Th Trabecular thickness Mean thickness of trabeculae, assessed using direct3D methods. mm
Tb.Pf Trabecular bone pattern factor
This is an index of connectivity of trabecular bone;
it calculates an index of relative convexity or
concavity of the total bone surface, on the principle
that concavity indicates connectivity (and the
presence of “nodes”), and convexity indicates
isolated disconnected structures (struts).
1/mm
Po(op) Open porosity (percent) Percent open porosity is the volume of open pores asa percent of the total VOI volume. %
Conn. Connectivity
One useful and fast algorithm for calculating the
Euler connectivity in 3D is the “Conneulor”.
It measures what might be called “redundant
connectivity”, the degree to which parts of the object
are multiply connected. It is a measure of how many
connections in a structure can be severed before the
structure falls into two separate pieces.
none
Micromorphometric data was collected by evaluation of the augmented bone of the test or control
group. Additional micromorphometric data was recorded by analyzing the native bone of the alveolar
ridge within the bone core biopsy samples of both test and control group. The microarchitectural
parameters of the augmented bone of the BoneAlbumin group and the ABBM group; the augmented
bone of the BoneAlbumin group and the native bone of the alveolar ridge; the augmented bone of the
ABBM group and the native bone of the alveolar ridge were compared.
Percentage values of each bone core biopsy sample were used to calculate descriptive statistics for
the hisomorphometrical and quantitative µCT analysis. The results were analyzed statistically using
the IBM SPSS Statistics 23 data analysis software program (IBM Corporation, New York, NY, USA).
The Kruskal Wallis One-way ANOVA test was used to compare two sets of data for the statistical
analysis of the histomorphometric results. One-way ANOVA test was used to compare three sets of
data for the statistical analysis of the micromorphometric results of the µCT. Values of p < 0.05 were
considered statistically significant.
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3. Results
3.1. Histology and Histomorphometry
At the time of re-entry, care was taken to preserve the anatomical orientation of the bone core
biopsies. In both study groups the bone substitute material integrated in the augmented areas with no
sign of inflammation or foreign body reaction. Altogether 1 out of 32 implants failed at 1 year follow
up in the entire study (BoneAlbumin group); the cause of failure was the lack of osseointegration
which was independent of the grafting procedure.
Histological analysis of the bone core biopsy samples obtained from the augmented sites of
the BoneAlbumin group revealed that particles of the albumin impregnated allograft underwent
considerable resorption and remodeling (Figure 2). Residual particles of the bone graft material were
surrounded by newly formed trabecular bone and marrow spaces. In 3 bone core biopsy samples
the allograft underwent complete remodeling with no residual bone graft particles present (Figure 2).
In contrast, histological analysis of the bone core biopsy samples obtained from the augmented sites
of the ABBM group revealed that the particles of the xenograft integrated in the augmented sinuses.
Particles of the xenograft intermixed with newly formed bone and marrow spaces surrounding the
particles (Figure 2).
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residues (bone graft particles, bgp) are seen. (B) A corresponding ABBM grafted section. Trabecular 
new bone (nfb) is present in a similar manner; however, the marrow (bm) is partially filled with the 
residues of  the  acellular graft material  (bgp). Panel  (C)  shows  the histomorphometry data of  the 
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Figure 2. Histological assessment of the graft and the newly formed bone tissue. (A) A representative
histological section with Hematoxylin-Eosin staining of a bone core biopsy sample harvested from
the area augmented using BoneAlbumin. New trabecular bone formation (newly formed bone, nfb)
is evident and the intertrabecular space is filled with bone marrow (bm). Only limited acellular graft
residues (bone graft articles, bgp) are see . (B) A corresponding ABBM grafted section. Trabecular
new bone (nfb) is present in a si ilar manner; however, the marrow (bm) is par ially filled with the
residues of the acellular graft material (bgp). Panel (C) shows the histomorphometry data of the stained
sections. Graft residues in the BoneAlbumin group are significantly less than those grafted with ABBM,
at the expense of marrow space. Data are presented as median–quartiles–ranges, * represents p < 0.05
with Kruskal Wallis One-way ANOVA test between the two experimental groups, respectively.
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3.2. µCT Results
3.2.1. Qualitative Analysis of the µCT Images
Qualitative analysis of the µCT images of the bone core biopsy samples obtained from the
augmented sinuses of both study groups showed marked difference in the appearance of the residual
native bone of the alveolar ridge and the augmented bone. Native bone of the alveolar ridge contained
thick trabeculae with wide marrow spaces in the biopsy specimens of both study groups. In the
augmented bone of the BoneAlbumin group particles of the albumin impregnated allograft and
the newly formed bone of the augmented area could not be differentiated based on radiolucency.
The augmented bone of the BoneAlbumin group consisted of trabeculae—thinner than that of the
native bone—in a complex structure with abundant nodes. In the augmented bone of the ABBM
group particles of the xenograft were characterized by greater radiodensity than the newly formed
bone. Particles of the xenograft were surrounded and connected by thin trabeculae with a complex
structure. The BoneAlbumin augmented tissue resembled a similar structure than that of the native
bone. Figure 3 presents representative µCT images of the bone core biopsy samples.
3.2.2. Quantitative Analysis of the µCT Images, Bone Microarchitecture Analysis
Quantitative analysis of the µCT confirmed the observations of the qualitative analysis. Native
bone of the alveolar ridge and augmented areas were differentiated based on their appearance in both
study groups. Morphometric data of the augmented areas of the BoneAlbumin group, the ABBM
group and of the native bone of the alveolar ridge were compared. Open porosity was higher in the
BoneAlbumin group, probably due to the denser marrow of the resorbing graft, while bone volume
fraction (BV/TV) is higher in the ABBM group due to the persisting high density graft particles.
The thickness of the newly formed trabeculae has not yet reached that of the native bone. Trabecular
pattern factor and Connectivity, metrics which reflect the microstructure of bone is approaching values
of the native bone, more in the BoneAlbumin group than in the ABBM group. The values of the
morphometric parameters that showed significant difference between the three sets of data and the
results of the statistical analysis are presented in Figure 3.
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BoneAlbumin group, while  in  the ABBM group  it  is comparable  to  that of native bone—note  that 
what  is  calculated  as  ‘bone’  in  this metric  contains  the unresorbed  graft  ceramic  (D). Trabecular 
thickness of  the BoneAlbumin group has not yet  reached  the  level of  that of  the native bone  (E). 
Trabecular  pattern  factor  (F)  which  describe  bone  geometry  is  closer  to  native  bone  in  the 
BoneAlbumin group than in the ABBM group. Open porosity is still somewhat higher than native in 
the BoneAlbumin group (G), while connectivity has reached the native level (H). Please note that in 
these parameters the bone value is a surrogate number for the newly formed bone and the residual 
graft. * signals p < 0.05 versus native bone. 
i 3. Panels (A–C) show repr sentative µCT images of the bone core biopsy samples at the
level of the residual native bone of the lveolar ridge (A), the level of the augmented bon grafted
using BoneAlbumin (B) and ABBM (C). Bone volume fraction (BV/TV) i still somewhat lower
, while in the AB M group it is comparable to that of native bone— ote that w t
is c lculated as ‘bone’ in this metric contains the unresorbed graft ceramic (D). Trabecular thickness of
t e BoneAlbumin group has not yet reached the l vel of that of th native bone (E). Trabecular pattern
factor (F) which describe bone geometry is closer to native bone in the BoneAlbumin gr up than in
the ABBM group. Open porosity is still somewhat higher than native in the BoneAlbumin group (G),
while connectivity has reached t e native level (H). Please note that in these parameters the bone value
is a surrogate number for the newly formed bone and the residual graft. * signals p < 0.05 versus
native bone.
Materials 2018, 11, 202 9 of 14
4. Discussion
In the present study we observed that a serum albumin enhanced bone allograft creates
a close-to-normal bone architecture. The anorganic xenograft persists and new bone is only growing
into the spaces around the particles of the graft material. Both histomorphometry and µCT analysis
confirmed that the new bone formed parallel with the resorption of BoneAlbumin and had a structure
closely resembling that of the native maxilla.
In several earlier studies µCT was employed to evaluate the microarchitecture of bone fillers
following two stage maxillary sinus floor augmetation. In these studies, the bone substitute materials
used were autogenous bone, anorganic bovine bone mineral (ABBM), synthetic β-tricalcium phosphate
(β-TCP), synthetic biphasic calcium phosphate, and porous titanium granules [41–51].
Anorganic bovine bone mineral is a poorly soluble calcium phosphate ceramic that is the result
of high-temperature treatment during processing. Clinical experience suggests that ABBM particles
integrate well in newly formed bone but undergo little resorption [52–55]. In contrast, freeze-dried bone
allografts are not subjected to elevated temperatures and the chemical composition of the inorganic
bone material is largely preserved. Allografts are typically preserved by lyophilization which maintains
the structure of the native bone and osseous apatite content as well as some of the structure proteins
and growth factors such as Bone Morphogenic Proteins (BMPs), however the native albumin content
of bone is washed away in standard allograft processing [56,57]. Limited growth of Ca2+ concentration
in ABBM augmented sinuses and increased remodeling in BoneAlbumin augmented sites explain that
the percentage of residual bone graft material and percentage of newly formed bone was significantly
lower in the biopsy samples obtained from sinuses grafted with BoneAlbumin than in those obtained
from sinuses grafted with ABBM. In the augmented bone of the ABBM group particles of the xenograft
were characterized by greater radiodensity than the newly formed bone unlike in the augmented
bone of the BoneAlbumin group where residual allograft particles were indistinguishable from newly
formed bone. This phenomenon can also be explained by the different manufacturing procedures of
the two initially similar raw materials, namely bovine or human bone. Bovine bone is subjected to high
temperatures during production, which enhances crystallinity resulting in a more radio dense material
while BoneAlbumin is manufactured by the Urist-protocol which includes partial demineralization of
the graft, producing a bone substitute with radiodensity similar to that of native bone [57,58].
The findings of theµCT analysis were consistent with those of the histological and histomorphometric
analysis. The microarchitecture of the ABBM augmented bone consisted of residual bone graft particles in
close contact with the newly formed bone surrounding it forming a dense structure with thin trabecules
and plate like marrow spaces, which is well described in the literature [42,45]. Although the endpoint
of the current study was 6 months, the persistence of mineralized xenograft particles is documented
for much longer, even decades, indicating that this is the final stage of remodeling and some xenograft
particles will remain in the human tissue until the lifetime of the patient [53–55,59]. The dense structure
showed little orientation in any direction. However, the microarchitecture of the BoneAlbumin augmented
bone consisted of extensively resorbed residual bone graft particles surrounded by newly formed bone
forming thin, plate and cylinder like trabecules with abundant marrow spaces. This observation is very
similar what was previously described in the patella [34].
The Higher Open porosity of the BoneAlbumin group compared to the native bone and the
ABBM group is due to the wide, interconnected marrow spaces of the remodeling bone. The Bone
volume fraction in the ABBM group is comparable to that of the native bone and higher than that of
the BoneAlbumin group. The Trabecular thickness of the BoneAlbumin group and the ABBM group is
significantly lower than that of the native bone. However, in these metrics, newly formed bone and
residual graft particles are calculated as bone. This means that, as the remodeling of the BoneAlbumin
is underway, these parameters are expected to reach the values of the native bone. The unresorbed
graft particles of ABBM, however, have integrated into the bone after 6 months and their remodeling
is not expected. In three cases of the current study there was no sign of the remaining graft material
in the BoneAlbumin group, indicating that even at 6 months’ time the remodeling can be complete.
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The microarchitecture of the bone in the BoneAlbumin group resembled more to that of the native
bone of the alveolar ridge, than that of the ABBM augmented ones when Tb.Pf and Conn. values of
bone microarchitecture are observed.
The same is observed with trabecular pattern factor (Tb.Pf), which describes the fractal dimensions
of the trabecular organization indicating the organic growth of the bone material. Interestingly,
trabecular pattern factor was also shown to be significantly better in an animal study where native
bone graft was compared to albumin-coated bone grafts, hence this effect is probably attributable to
the albumin addition only [31].
One useful and fast algorithm for calculating the Euler connectivity in 3D is the “Conneulor”.
It measures what might be called redundant connectivity, the degree to which parts of the object are
multiply connected [40]. The connectivity of the augmented bone of the ABBM group was significantly
higher than that of the augmented bone of the BoneAlbumin group and that of the native bone of the
alveolar ridge. The connectivity of the augmented bone of the BoneAlbumin group and that of the
native bone of the alveolar ridge showed no statistically significant difference. The dense structure
of residual particles of the non-resorbable material (ABBM) surrounded by thin trabecules of newly
formed bone is responsible for higher connectivity values.
In addition to being less processed and obviously more ‘human’ than ABBM, BoneAlbumin is
saturated with serum albumin in a lyophilized form. Empirical observations in any stem cell lab
proves that serum albumin in up to 10% concentrations must be a standard constituent of cell culture
media, otherwise the bone marrow derived mesenchymal stem cells (BMSCs) just do not grow. In the
native environment of the bone and marrow niche, bone cells generate albumin and secrete it into
the extracellular space as the first protein in case of bone injury [36]. It has also been shown that
albumin is physiologically present in bone tissue, therefore, replenishing the albumin content of bone
allografts is required if one tries to build a graft as close to the native tissue as possible [30–35]. Several
earlier studies in both animals and humans have shown that albumin augmentation results in better
bone formation, however, this is the first study that shows its beneficial effects in the challenging
environment of the maxilla [30,32–34].
The justification of using bone fillers that never fully resorb comes from the clinical concern of
premature resorption. While this is not an issue in most orthopedic indications, the high metabolic
turnover and exposed anatomy of the alveolar ridges make these locations especially prone to the
resorption of a bone filler [52,57,60]. Supplementation of the bone marrow niche with albumin
kick-started a bone regeneration process that resulted in new bone closely resembling that of the
native maxilla. The bone graft can thus perform its original purpose of directing new tissue formation
while the graft material disappears completely, leaving only the patient’s own new bone in its place.
As the patient population for sinus lift is expected to live several decades with their new bone,
it is especially important that it is native bone which remodels and ages naturally during their
lifetime. Limitations of the current study are the relatively short investigational timescale and the
microstructural nature of the outcome measures, that are sometimes hard to understand from a clinical
point of view. Percentage values of each bone core biopsy sample were used to calculate descriptive
statistics for the hisomorphometrical and quantitative µCT analysis. In some cases, more than one
bone core biopsy specimens were harvested from the same patient which might be a limitation of this
study. The use of ABBM is evidently adequate as a bone filler in the maxilla despite the persistent
graft particles and the disturbed histological picture. One would even argue that the remaining graft
residue is beneficial to hold the shape and may efficiently support the implant. The timeline of the
current investigation is limited to 6 months, while the true clinical benefits of a fully remodeled
graft may only be important years or decades later when differences of ageing between a native
bone tissue and bone with residual grafts become evident. However, this question is currently only
speculative, and a register-type study may answer it when enough BoneAlbumin grafts are implanted
and time elapsed.
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5. Conclusions
In our study we successfully utilized maxillary sinus floor augmentation with a lateral window
technique with anorganic bovine bone mineral or albumin impregnated allograft to augment
the posterior maxilla prior to implantation. Data from the histological, histomorphometrical
and µCT analysis concluded that ABBM integrates with new bone while BoneAlbumin mainly
undergoes remodeling.
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